Future directions in the medical treatment of primary sclerosing cholangitis: the need for combination drug therapy.
Fong
D G
DG
Lindor
K D
KD
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D019819:Budesonide / Q000627:therapeutic use; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D015209:Cholangitis, Sclerosing / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005762:Gastroenterology / Q000639:trends*; D006801:Humans; D011241:Prednisone / Q000627:therapeutic use; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D002756:Cholagogues and Choleretics; D019819:Budesonide; D014580:Ursodeoxycholic Acid; D011241:Prednisone